Arginine deiminase enhances MCF-7 cell radiosensitivity by inducing changes in the expression of cell cycle-related proteins

Hwan Park, Jun Beom Lee, Young Jun Shim, Yong Jae Shin, Seong Yun Jeong, Jun Seo Oh, Gil-Hong Park, Kee Ho Lee, Bon Hong Min

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

After successful clinical application, arginine deiminase (ADI) has been proposed to be a new cancer therapeutic. In the present study, we examined the effect of ADI in combination with ionizing radiation (IR) on MCF-7 cell growth and clonogenic cell death. Cell growth was inhibited by IR in a dose-dependent manner and ADI enhanced the radiosensitivity. ADI itself did not suppress the growth of MCF-7 cells due to the high level of expression of argininosuccinate synthetase (ASS), which convert citrulline, a product of arginine degradation by ADI, to arginine. Previously, it was suggested that ammonia, another product of arginine degradation by ADI, is the main cause of the growth inhibition of irradiated hepatoma cells contaminated with ADI-expressing mycoplasma [van Rijn et al. (2003)]. However, we found that ammonia is not the only factor that enhances radiosensitivity, as enhancement was also observed in the absence of ammonia. In order to identify the enhancing effect, levels of ASS and proteins related to the cell cycle were examined. ASS was unchanged by ADI plus IR, but p21 (a CDK inhibitor) was upregulated and c-Myc downregulated. These findings indicate that changes in the expressions of cell cycle proteins are involved in the enhancement of radiosensitivity by ADI. We suggest that ADI is a potential adjunct to cancer therapy.

Original languageEnglish
Pages (from-to)305-311
Number of pages7
JournalMolecules and Cells
Volume25
Issue number2
Publication statusPublished - 2008 Apr 30

Fingerprint

Cell Cycle Proteins
Radiation Tolerance
MCF-7 Cells
Argininosuccinate Synthase
Ionizing Radiation
Ammonia
Arginine
Growth
arginine deiminase
Citrulline
Mycoplasma
Hepatocellular Carcinoma
Neoplasms
Cell Cycle
Cell Death
Down-Regulation

Keywords

  • ADI
  • ASS
  • c-Myc
  • IR
  • p21

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

Arginine deiminase enhances MCF-7 cell radiosensitivity by inducing changes in the expression of cell cycle-related proteins. / Park, Hwan; Lee, Jun Beom; Shim, Young Jun; Shin, Yong Jae; Jeong, Seong Yun; Oh, Jun Seo; Park, Gil-Hong; Lee, Kee Ho; Min, Bon Hong.

In: Molecules and Cells, Vol. 25, No. 2, 30.04.2008, p. 305-311.

Research output: Contribution to journalArticle

Park, Hwan ; Lee, Jun Beom ; Shim, Young Jun ; Shin, Yong Jae ; Jeong, Seong Yun ; Oh, Jun Seo ; Park, Gil-Hong ; Lee, Kee Ho ; Min, Bon Hong. / Arginine deiminase enhances MCF-7 cell radiosensitivity by inducing changes in the expression of cell cycle-related proteins. In: Molecules and Cells. 2008 ; Vol. 25, No. 2. pp. 305-311.
@article{0cd438e1bba549fb9b4f9c507b402773,
title = "Arginine deiminase enhances MCF-7 cell radiosensitivity by inducing changes in the expression of cell cycle-related proteins",
abstract = "After successful clinical application, arginine deiminase (ADI) has been proposed to be a new cancer therapeutic. In the present study, we examined the effect of ADI in combination with ionizing radiation (IR) on MCF-7 cell growth and clonogenic cell death. Cell growth was inhibited by IR in a dose-dependent manner and ADI enhanced the radiosensitivity. ADI itself did not suppress the growth of MCF-7 cells due to the high level of expression of argininosuccinate synthetase (ASS), which convert citrulline, a product of arginine degradation by ADI, to arginine. Previously, it was suggested that ammonia, another product of arginine degradation by ADI, is the main cause of the growth inhibition of irradiated hepatoma cells contaminated with ADI-expressing mycoplasma [van Rijn et al. (2003)]. However, we found that ammonia is not the only factor that enhances radiosensitivity, as enhancement was also observed in the absence of ammonia. In order to identify the enhancing effect, levels of ASS and proteins related to the cell cycle were examined. ASS was unchanged by ADI plus IR, but p21 (a CDK inhibitor) was upregulated and c-Myc downregulated. These findings indicate that changes in the expressions of cell cycle proteins are involved in the enhancement of radiosensitivity by ADI. We suggest that ADI is a potential adjunct to cancer therapy.",
keywords = "ADI, ASS, c-Myc, IR, p21",
author = "Hwan Park and Lee, {Jun Beom} and Shim, {Young Jun} and Shin, {Yong Jae} and Jeong, {Seong Yun} and Oh, {Jun Seo} and Gil-Hong Park and Lee, {Kee Ho} and Min, {Bon Hong}",
year = "2008",
month = "4",
day = "30",
language = "English",
volume = "25",
pages = "305--311",
journal = "Molecules and Cells",
issn = "1016-8478",
publisher = "Korean Society for Molecular and Cellular Biology",
number = "2",

}

TY - JOUR

T1 - Arginine deiminase enhances MCF-7 cell radiosensitivity by inducing changes in the expression of cell cycle-related proteins

AU - Park, Hwan

AU - Lee, Jun Beom

AU - Shim, Young Jun

AU - Shin, Yong Jae

AU - Jeong, Seong Yun

AU - Oh, Jun Seo

AU - Park, Gil-Hong

AU - Lee, Kee Ho

AU - Min, Bon Hong

PY - 2008/4/30

Y1 - 2008/4/30

N2 - After successful clinical application, arginine deiminase (ADI) has been proposed to be a new cancer therapeutic. In the present study, we examined the effect of ADI in combination with ionizing radiation (IR) on MCF-7 cell growth and clonogenic cell death. Cell growth was inhibited by IR in a dose-dependent manner and ADI enhanced the radiosensitivity. ADI itself did not suppress the growth of MCF-7 cells due to the high level of expression of argininosuccinate synthetase (ASS), which convert citrulline, a product of arginine degradation by ADI, to arginine. Previously, it was suggested that ammonia, another product of arginine degradation by ADI, is the main cause of the growth inhibition of irradiated hepatoma cells contaminated with ADI-expressing mycoplasma [van Rijn et al. (2003)]. However, we found that ammonia is not the only factor that enhances radiosensitivity, as enhancement was also observed in the absence of ammonia. In order to identify the enhancing effect, levels of ASS and proteins related to the cell cycle were examined. ASS was unchanged by ADI plus IR, but p21 (a CDK inhibitor) was upregulated and c-Myc downregulated. These findings indicate that changes in the expressions of cell cycle proteins are involved in the enhancement of radiosensitivity by ADI. We suggest that ADI is a potential adjunct to cancer therapy.

AB - After successful clinical application, arginine deiminase (ADI) has been proposed to be a new cancer therapeutic. In the present study, we examined the effect of ADI in combination with ionizing radiation (IR) on MCF-7 cell growth and clonogenic cell death. Cell growth was inhibited by IR in a dose-dependent manner and ADI enhanced the radiosensitivity. ADI itself did not suppress the growth of MCF-7 cells due to the high level of expression of argininosuccinate synthetase (ASS), which convert citrulline, a product of arginine degradation by ADI, to arginine. Previously, it was suggested that ammonia, another product of arginine degradation by ADI, is the main cause of the growth inhibition of irradiated hepatoma cells contaminated with ADI-expressing mycoplasma [van Rijn et al. (2003)]. However, we found that ammonia is not the only factor that enhances radiosensitivity, as enhancement was also observed in the absence of ammonia. In order to identify the enhancing effect, levels of ASS and proteins related to the cell cycle were examined. ASS was unchanged by ADI plus IR, but p21 (a CDK inhibitor) was upregulated and c-Myc downregulated. These findings indicate that changes in the expressions of cell cycle proteins are involved in the enhancement of radiosensitivity by ADI. We suggest that ADI is a potential adjunct to cancer therapy.

KW - ADI

KW - ASS

KW - c-Myc

KW - IR

KW - p21

UR - http://www.scopus.com/inward/record.url?scp=44949240553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44949240553&partnerID=8YFLogxK

M3 - Article

VL - 25

SP - 305

EP - 311

JO - Molecules and Cells

JF - Molecules and Cells

SN - 1016-8478

IS - 2

ER -